莎普爱思：获得聚乙烯醇滴眼液药品注册证书

Core Viewpoint - The company Shapais (603168) has received approval from the National Medical Products Administration for its polyethylene glycol eye drops, which can be used to prevent or treat symptoms such as dry eyes, foreign body sensation, and eye fatigue [1] Summary by Relevant Categories Product Approval - The polyethylene glycol eye drops are classified as an ophthalmic preparation with a specification of 1.4% (0.4 ml: 5.6 mg) [1] - The approval signifies a significant milestone for the company in expanding its product offerings in the ophthalmic market [1] Research and Development Investment - The cumulative R&D investment for this product has reached approximately 8.11 million RMB [1] - This investment reflects the company's commitment to developing innovative solutions for eye care [1]